These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description. Barresi V, Lionti S, Raso A, Esposito F, Cannavò S, Angileri FF. Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337 [Abstract] [Full Text] [Related]
3. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases. Holdhof D, Johann PD, Spohn M, Bockmayr M, Safaei S, Joshi P, Masliah-Planchon J, Ho B, Andrianteranagna M, Bourdeaut F, Huang A, Kool M, Upadhyaya SA, Bendel AE, Indenbirken D, Foulkes WD, Bush JW, Creytens D, Kordes U, Frühwald MC, Hasselblatt M, Schüller U. Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994 [Abstract] [Full Text] [Related]
5. Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT. Nakata S, Nobusawa S, Hirose T, Ito S, Inoshita N, Ichi S, Amatya VJ, Takeshima Y, Sugiyama K, Sonoda Y, Haga H, Hirato J, Nakazato Y, Yokoo H. Am J Surg Pathol; 2017 Jul; 41(7):932-940. PubMed ID: 28338502 [Abstract] [Full Text] [Related]
6. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, Vogelgesang S, Rodriguez FJ, Brett FM, McLendon R, Bodi I, Burel-Vandenbos F, Keyvani K, Tippelt S, Poulsen FR, Lipp ES, Giannini C, Reifenberger G, Kuchelmeister K, Pietsch T, Kordes U, Siebert R, Frühwald MC, Johann PD, Sill M, Kool M, von Deimling A, Paulus W, Hasselblatt M. Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806 [Abstract] [Full Text] [Related]
7. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor. Duan Z, Yao K, Yang S, Qu Y, Ren M, Zhang Y, Fan T, Zhao H, Gao J, Feng J, Fan X, Qi X. Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041 [Abstract] [Full Text] [Related]
8. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors. Frühwald MC, Hasselblatt M, Nemes K, Bens S, Steinbügl M, Johann PD, Kerl K, Hauser P, Quiroga E, Solano-Paez P, Biassoni V, Gil-da-Costa MJ, Perek-Polnik M, van de Wetering M, Sumerauer D, Pears J, Stabell N, Holm S, Hengartner H, Gerber NU, Grotzer M, Boos J, Ebinger M, Tippelt S, Paulus W, Furtwängler R, Hernáiz-Driever P, Reinhard H, Rutkowski S, Schlegel PG, Schmid I, Kortmann RD, Timmermann B, Warmuth-Metz M, Kordes U, Gerss J, Nysom K, Schneppenheim R, Siebert R, Kool M, Graf N. Neuro Oncol; 2020 Jul 07; 22(7):1006-1017. PubMed ID: 31883020 [Abstract] [Full Text] [Related]
9. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature. Voisin MR, Ovenden C, Tsang DS, Gupta AA, Huang A, Gao AF, Diamandis P, Almeida JP, Gentili F. World Neurosurg; 2019 Jul 07; 127():336-345. PubMed ID: 31004861 [Abstract] [Full Text] [Related]
10. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors. Tegeder I, Thiel K, Erkek S, Johann PD, Berlandi J, Thatikonda V, Frühwald MC, Kool M, Jeibmann A, Hasselblatt M. J Neurooncol; 2019 Jan 07; 141(1):43-55. PubMed ID: 30446899 [Abstract] [Full Text] [Related]
11. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1). Peterson JEG, Bavle A, Mehta VP, Rauch RA, Whitehead WE, Mohila CA, Su JM, Adesina AM. Pediatr Dev Pathol; 2019 Jan 07; 22(2):161-165. PubMed ID: 30470167 [Abstract] [Full Text] [Related]
13. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Pinto EM, Hamideh D, Bahrami A, Orr BA, Lin T, Pounds S, Zambetti GP, Pappo AS, Gajjar A, Agnihotri S, Broniscer A. Acta Neuropathol; 2018 Aug 07; 136(2):315-326. PubMed ID: 29428974 [Abstract] [Full Text] [Related]
15. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort. Benesch M, Nemes K, Neumayer P, Hasselblatt M, Timmermann B, Bison B, Ebetsberger-Dachs G, Bourdeaut F, Dufour C, Biassoni V, Morales La Madrid A, Entz-Werle N, Laithier V, Quehenberger F, Weis S, Sumerauer D, Siebert R, Bens S, Schneppenheim R, Kool M, Modena P, Fouyssac F, C Frühwald M. Pediatr Blood Cancer; 2020 Jan 07; 67(1):e28022. PubMed ID: 31571386 [Abstract] [Full Text] [Related]
16. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup. Zin F, Cotter JA, Haberler C, Dottermusch M, Neumann J, Schüller U, Schweizer L, Thomas C, Nemes K, Johann PD, Kool M, Frühwald MC, Paulus W, Judkins A, Hasselblatt M. Brain Pathol; 2021 Sep 07; 31(5):e12967. PubMed ID: 33938067 [Abstract] [Full Text] [Related]
20. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Paassen I, Williams J, Ríos Arceo C, Ringnalda F, Mercer KS, Buhl JL, Moreno N, Federico A, Franke NE, Kranendonk M, Upadhyaya SA, Kerl K, van de Wetering M, Clevers H, Kool M, Hoving EW, Roussel MF, Drost J. Oncogene; 2023 May 07; 42(20):1661-1671. PubMed ID: 37020038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]